Needham & Company
-
SCYNEXIS Announces Pricing of $30.0 Million Public Offering of Common Stock and Warrants
-
UPDATE: Pre-Open Movers 05/09: (VRX) (NVMI) (ODP) Higher; (SCYX) (HTZ) (NVRO) Lower (more...)
-
Needham & Company Downgrades SCYNEXIS (SCYX) to Hold as FDA Requests More Info on IV SCY-078
-
SCYNEXIS, Inc. to Present at the 16th Annual Needham Healthcare Conference
-
Pre-Open Stock Movers 12/13: (NVCN) (AKAO) (SCYX) Higher; (PRTO) (INOV) (BDSI) Lower (more...)
-
Notable Analyst Rating Changes 10/7: (VSLR) (RRC) (DFT) Upgraded; (SEDG) (TSN) (HEES) Downgraded
-
Notable 52-Week Highs and Lows 7/14: (GSS) (YUM) (CSOD) High; (RNVA) (SCYX) Low
-
Scynexis (SCYX) Enters Common Stock, Warrants Underwriting Agreement with Guggenheim
-
Scynexis (SCYX) Prices $22.5M Common Stock, Warrants Offering
-
SCYNEXIS Announces Pricing of $22.5 Million Public Offering of Common Stock and Warrants
-
SCYNEXIS, Inc. to Present at the 15th Annual Needham Healthcare Conference
-
Needham & Company Starts SCYNEXIS (SCYX) at Buy, $16 PT
-
Scynexis (SCYX) Prices 4.68M Common Shares at $7.70/Share
-
SCYNEXIS Announces Pricing of Public Offering of Common Stock
-
SCYNEXIS Announces Launch of Public Offering of Common Stock

